Real-time enrollment status for this autoimmune lymphoproliferative syndrome clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 8:48 AM UTC
| NCT Number | NCT06730126 |
| Recruiting Status | Recruiting |
| Condition | Autoimmune Lymphoproliferative Syndrome |
| Phase | Clinical Trial |
| Target Enrollment | 15 participants |
| Active Locations | 3 sites in the US |
| Sponsor | National Institute of Allergy and Infectious Diseases (NIAID) |
| Last Updated on CT.gov | January 28, 2026 (Jan 28, 2026) |
As of March 2, 2026: Clinical trial NCT06730126 is currently recruiting participants. This clinical trial study for autoimmune lymphoproliferative syndrome is actively seeking new participants at 3 locations across the United States. The study is sponsored by National Institute of Allergy and Infectious Diseases (NIAID). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06730126 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06730126 was last updated Jan 28, 2026 (January 28, 2026). HelloStudys verifies this status automatically.